Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2025-02-17

Clinical Trial Update: A Comparative Study of Intrathecal Dexmedetomidine and Fentanyl As Additives to Bupivacaine in Pott's Fracture [Phase 1]

View source ↗

Summary

Phase 1 trial comparing intrathecal dexmedetomidine vs. fentanyl as additives to bupivacaine for postoperative pain relief; the study has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Bupivacaine (Bupivacaine)
  • Dexmedetomidine (Dexmedetomidine)
  • FENTANYL (FENTANYL)

Snippet

Sponsor: Ain Shams University | Conditions: Post Operative Pain | Phase 1 | Status: COMPLETED